CYSB2400114 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2024-05-15 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
CYSB2200240 | 静注人免疫球蛋白(10%) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2022-10-10 | | Guizhou Taibang Biological Products Co Ltd | | | view |
CYSB2400305 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2024-11-21 | | Guangdong Shuanglin Bio-Pharmacy Co Ltd | | | view |
CYSB2101160 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2021-08-18 | | Hualan Biological Engineering Inc | | | view |
CYSB2200138 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2022-06-07 | | Shanghai RAAS Blood Products Co Ltd | | | view |
CYSB2500018 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2025-01-17 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
CXSL2400234 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products(3.4) | New Drug Application | 2024-04-16 | | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | | | view |
CYSB2200065 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2022-03-01 | | Shenzhen Weiguang Biological Products Co Ltd | | | view |
CYSB2400260 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products(3.4) | Supplementary Application | 2024-09-26 | | Shanxi Kangbao Biological Product Co Ltd | | | view |
CYSB2200109 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2022-04-29 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
CYSB2101142 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2021-08-10 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
CXSL2500022 | 静注人免疫球蛋白(10%) | human immunoglobulin(PH4) | Injection | Biological Products(3.2) | New Drug Application | 2025-01-08 | | Guangdong Shuanglin Bio-Pharmacy Co Ltd | | | view |
CYSB2300149 | 静注人免疫球蛋白(10%) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2023-08-02 | | Guangdong Shuanglin Bio-Pharmacy Co Ltd | | | view |
CYSB2101073 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2021-05-24 | | Hualan Biological Engineering Inc | | | view |
CYSB2400277 | 静注人免疫球蛋白 | human immunoglobulin(PH4) | Injection | Biological Products(原15) | Supplementary Application | 2024-10-23 | | Hualan Biological Engineering Inc | | | view |
CXSL2101366 | 静注人免疫球蛋白(10%) | human immunoglobulin(PH4) | Injection | Biological Products(3.2) | New Drug Application | 2021-10-14 | | China Resources Boya Bio-pharmaceutical Group Co Ltd | | | view |
CYSB2101111 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2021-07-13 | | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | | | view |
CYSB2500020 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2025-01-17 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
CYSB2400062 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products(原15) | Supplementary Application | 2024-03-05 | | China Resources Boya Bio-pharmaceutical Group Co Ltd | | | view |
CYSB2101141 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2021-08-10 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |